Trial · NCT03480022
Results by group58
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 58
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Absolute Body Weight (BW) | Liraglutide Pen Injector (Saxenda) | 104.7 | Standard Error 2.9 | kilogram | |
| Absolute Body Weight (BW) | Placebo Liraglutide Pen Injector | 117.9 | Standard Error 5 | kilogram | |
| Free Androgen Index (FAI) | Liraglutide Pen Injector (Saxenda) | 5.98 | Standard Error 0.6 | index score | |
| Free Androgen Index (FAI) | Placebo Liraglutide Pen Injector | 6.4 | Standard Error .75 | index score | |
| Body Mass Index (BMI) | Liraglutide Pen Injector (Saxenda) | 39.1 | Standard Error 1.1 | kilogram/meter squared | |
| Body Mass Index (BMI) | Placebo Liraglutide Pen Injector | 43.4 | Standard Error 1.8 | kilogram/meter squared | |
| Change in Percent Body Weight | Liraglutide Pen Injector (Saxenda) | 5.7 | Standard Error 0.75 | percentage loss in body weight | |
| Change in Percent Body Weight | Placebo Liraglutide Pen Injector | 1.4 | Standard Error 1.09 | percentage loss in body weight | |
| 5% Weight Loss From Baseline | Liraglutide Pen Injector (Saxenda) | 25 | Participants | ||
| 5% Weight Loss From Baseline | Placebo Liraglutide Pen Injector | 5 | Participants | ||
| 10% Body Weight Loss From Baseline | Liraglutide Pen Injector (Saxenda) | 13 | Participants | ||
| 10% Body Weight Loss From Baseline | Placebo Liraglutide Pen Injector | 2 | Participants | ||
| Abdominal Adiposity (Waist Circumference [WC] | Liraglutide Pen Injector (Saxenda) | 100.9 | Standard Error 2.0 | centimeters | |
| Abdominal Adiposity (Waist Circumference [WC] | Placebo Liraglutide Pen Injector | 109.9 | Standard Error 3.3 | centimeters | |
| Waist-to-Hip Ratio | Liraglutide Pen Injector (Saxenda) | 0.81 | Standard Error 0.009 | ratio | |
| Waist-to-Hip Ratio | Placebo Liraglutide Pen Injector | 0.85 | Standard Error 0.015 | ratio | |
| Waist-to Height Ratio [WHtR]) | Liraglutide Pen Injector (Saxenda) | 0.62 | Standard Error 0.014 | ratio | |
| Waist-to Height Ratio [WHtR]) | Placebo Liraglutide Pen Injector | 0.67 | Standard Error 0.02 | ratio | |
| Total Fat Mass Evaluated by DEXA | Liraglutide Pen Injector (Saxenda) | 49.3 | Standard Error 2.1 | kilogram | |
| Total Fat Mass Evaluated by DEXA | Placebo Liraglutide Pen Injector | 56.8 | Standard Error 3.3 | kilogram |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03480022/results